首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Opioid enhancement of evoked Met5enkephalin release requires activation of cholinergic receptors: possible involvement of intracellular calcium.
【2h】

Opioid enhancement of evoked Met5enkephalin release requires activation of cholinergic receptors: possible involvement of intracellular calcium.

机译:阿片样物质增强诱发的Met5脑啡肽释放需要激活胆碱能受体:细胞内钙可能参与。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Previous work from this laboratory has shown that the electrically evoked release of enkephalin from the guinea pig myenteric plexus is regulated by an opiate receptor-mediated, concentration-dependent mechanism. Low concentrations (nanomolar) of opioids enhance release, whereas higher concentrations (10-100 nM) inhibit release. Each opioid effect is mediated by a different guanine nucleotide-binding protein. We now demonstrate that activation of cholinergic receptors in the myenteric plexus is a prerequisite for opioid excitatory effects, but not inhibitory effects, on enkephalin release. Pretreatment with the muscarinic cholinergic receptor antagonist atropine abolishes the opioid facilitation of stimulated enkephalin release but does not alter the inhibition of release that is observed with higher concentrations of opioid agonist. Exposure to the calcium ionophore A23187 overcomes the abolishment of opioid enhancement of enkephalin release produced by cholinergic receptor blockade. In tissue treated with both atropine and A23187, the magnitude of the opioid enhancement of release is indistinguishable from that observed in untreated preparations. This suggests that the lack of stimulation-induced generation of elevated cytosolic calcium is responsible for the abolishment of facilitory opioid effects when cholinergic receptors are blocked. The known coupling of muscarinic receptors to phospholipase C activation and the generation of inositol trisphosphate (which elevates cytosolic calcium) could suggest that this second messenger is critical for the manifestation of opioid facilitation of enkephalin release.
机译:该实验室的先前工作表明,脑啡肽从豚鼠肌间神经丛的电诱发释放受阿片受体介导的浓度依赖性机制的调节。低浓度(纳摩尔)的阿片类药物可增强释放,而较高浓度(10-100 nM)可抑制释放。每种阿片样物质的作用都由不同的鸟嘌呤核苷酸结合蛋白介导。我们现在证明,在肠神经丛中胆碱能受体的激活是阿片样物质对脑啡肽的兴奋作用而不是抑制作用的先决条件。用毒蕈碱胆碱能受体拮抗剂阿托品进行的预处理消除了刺激的脑啡肽释放的阿片类药物促进作用,但并没有改变在更高浓度的阿片类药物激动剂中观察到的释放抑制作用。钙离子载体A23187的暴露克服了由胆碱能受体阻滞产生的阿片样物质增强的脑啡肽释放的消除。在用阿托品和A23187处理过的组织中,阿片类药物释放的增强幅度与未处理制剂中观察到的没有区别。这表明当胆碱能受体被阻滞时,缺乏刺激引起的胞质钙升高的产生是导致促进阿片样物质作用消失的原因。毒蕈碱受体与磷脂酶C活化的已知偶联以及肌醇三磷酸酯的生成(提高胞质钙)可能表明,该第二信使对于促进脑啡肽释放的阿片样物质的表达至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号